Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality：a Randomized Controlled Study

NCT03966339 is registered in ClinicalTrials.gov with Reproductive & Genetic Hospital of CITIC-Xiangya as lead sponsor.

NCT NCT03966339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03966339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality：a Randomized Controlled Study
Lead sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2019
Completion date
December 31, 2022
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility,female